Causality assessment in pharmacovigilance: The French method and its successive updates

Area of Science:

• Pharmacovigilance
• Drug Safety
• Clinical Pharmacology

Background:

• Causality assessment methods for adverse drug reactions (ADRs) emerged with pharmacovigilance in the 1970s-1980s.
• The French method, originating from pioneering works, is an early example of such a systematic approach.
• Its initial publication was in 1978, with subsequent revisions in 1985 and 2011.

Purpose of the Study:

• To present the main alterations and improvements made to the French causality assessment method over its successive versions.
• To highlight how the method has evolved to enhance clarity, formalize criteria, and maintain user-friendliness.
• To underscore the importance of causality assessment in understanding drug-adverse reaction links.

Main Methods:

• Review and comparison of the original 1978 French method with its 1985 and 2011 updated versions.
• Analysis of alterations presented in annexed tables, focusing on changes in presentation and definitions.
• Evaluation of the method's ease of use and formalization of causality criteria.

Main Results:

• Successive versions of the French method demonstrate improved presentation and more formalized definitions for causality assessment criteria.
• The method has been consistently refined to remain user-friendly despite increased formalization.
• Alterations primarily focus on enhancing the clarity and structure of the assessment process.

Conclusions:

• Causality assessment, exemplified by the French method, is crucial for formalizing and explaining the link between drugs and adverse reactions.
• The method contributes significantly to accurate diagnosis and appropriate management of adverse drug reactions.
• Refined causality assessment methods improve the quality and relevance of data within pharmacovigilance databases.